We are live on ! Find out more
ONTXW

Onconova Therapeutics, Inc. Warrants
ONTXW

Delisted

ONTXW was delisted on the 23rd of July, 2021.

Back to rankings

5 hedge funds and large institutions have $1.29M invested in Onconova Therapeutics, Inc. Warrants in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

27% less capital invested

Capital invested by funds: $1.76M → $1.29M (-$468K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$155K
2
AFM
Anson Funds Management
Texas
+$84.1K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$30.8K

ONTXW Hedge Fund Activity: Q4 2016 in Review

5 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q4 2016, worth a combined $1.29M — down 27% from $1.76M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ONTXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $155K. The largest seller was Sabby Management, cutting an estimated $30.8K.

  • 5 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q4 2016, up from 3 in Q3 2016.
  • Funds reported $1.29M of Onconova Therapeutics, Inc. Warrants stock for Q4 2016, down 27% quarter-over-quarter.
  • 2 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q4 2016 and 0 closed out, a net change of +2 holders.
  • The largest Onconova Therapeutics, Inc. Warrants buyer in Q4 2016 was Susquehanna International Group, an estimated $155K added.
  • The largest Onconova Therapeutics, Inc. Warrants seller in Q4 2016 was Sabby Management, an estimated $30.8K sold.

Based on aggregated 13F filings for Q4 2016.